Evolus Strategic Advantage and Growth

LOVVOLUS GROWING OUR PRESENCE IN LARGE & UNDERPENETRATED MARKETS EVOLUS IS CONTINUING TO GAIN SHARE IN THE FAST-GROWING NEUROTOXIN MARKET 12% 10% 8% 6% JEUVEAU SHARE OF TOXIN MARKET OVER THE LAST FEW YEARS* 4% 4% 2% 7% 7% 9% 11% prabotulinumtoxinA 0% injection 2019 2020 2021 2022 2023 Jeuveau prabotulinumtoxinA-xvfs injection "NUCEIVA * Market share is a company estimate. De 60

View entire presentation